Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study

Background:. Between 75% and 80% of patients with sepsis arrive in the hospital through the emergency department. Early diagnosis is important to alter patient prognosis, but currently, there is no reliable biomarker. The innate immune response links inflammation and coagulation. Several coagulation...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jaskirat Arora, MBBS, Jennifer A. Klowak, MD, MSc, FRCPC, Sameer Parpia, MSc, PhD, Marcelo Zapata-Canivilo, MD, Walaa Faidi, MSc, Christopher Skappak, MD, PhD, Rachael Gregoris, BHSc, Colin A. Kretz, BSc, PhD, Dhruva J. Dwivedi, BSc, MSc, PhD, Kerstin de Wit, BSc, MSc, MB ChB, MD, FRCPC, FRCEM, MRCP, Michelle Welsford, BSc, MD, FACEP, CCPE, FRCPC, Alison Fox-Robichaud, MSc, MD, FRCPC, on behalf of the Canadian Critical Care Translational Biology Group, Patricia Liaw, Jamie Hutchison, Jane Batt, Sean Gill, Jean-Francois Cailhier
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/97e9fdeb85504be09052fd1bdf14f6b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:97e9fdeb85504be09052fd1bdf14f6b1
record_format dspace
spelling oai:doaj.org-article:97e9fdeb85504be09052fd1bdf14f6b12021-11-25T07:54:32ZDiagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study2639-802810.1097/CCE.0000000000000414https://doaj.org/article/97e9fdeb85504be09052fd1bdf14f6b12021-04-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000414https://doaj.org/toc/2639-8028Background:. Between 75% and 80% of patients with sepsis arrive in the hospital through the emergency department. Early diagnosis is important to alter patient prognosis, but currently, there is no reliable biomarker. The innate immune response links inflammation and coagulation. Several coagulation -related biomarkers are associated with poor prognosis in the ICU. The role of coagulation biomarkers to aid in early sepsis diagnosis has not previously been investigated. The objective of our study is to determine the individual or combined accuracy of coagulation and inflammation biomarkers with standard biochemical tests to diagnose adult septic patients presenting to the emergency department. Methods:. in the Emergency Department is a prospective, observational cohort study with a target enrolment of 250 suspected septic patients from two Canadian emergency departments. The emergency physicians will enroll patients with suspected sepsis. Blood samples will be collected at two time points (initial presentation and 4 hr following). Patients will be adjudicated into septic, infected, or not infected status in accordance with the Sepsis-3 definitions. Patient demographics, cultures, diagnosis, and biomarkers will be reported using descriptive statistics. Optimal cut off values with sensitivity and specificity for each biomarker will be determined using C-statistics to distinguish between septic and nonseptic patients. Stepwise multiple logistic regression analysis with exclusion of nonsignificant covariates from the final model will be used to establish a panel of biomarkers. Conclusions:. Our protocol describes the processes and methods for a pragmatic observational biomarker study in the emergency department. This study will seek to determine the potential diagnostic importance of early coagulation abnormalities to identify additional tools for sepsis diagnosis.Jaskirat Arora, MBBSJennifer A. Klowak, MD, MSc, FRCPCSameer Parpia, MSc, PhDMarcelo Zapata-Canivilo, MDWalaa Faidi, MScChristopher Skappak, MD, PhDRachael Gregoris, BHScColin A. Kretz, BSc, PhDDhruva J. Dwivedi, BSc, MSc, PhDKerstin de Wit, BSc, MSc, MB ChB, MD, FRCPC, FRCEM, MRCPMichelle Welsford, BSc, MD, FACEP, CCPE, FRCPCAlison Fox-Robichaud, MSc, MD, FRCPCon behalf of the Canadian Critical Care Translational Biology GroupPatricia LiawJamie HutchisonJane BattSean GillJean-Francois CailhierWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 4, p e0414 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Jaskirat Arora, MBBS
Jennifer A. Klowak, MD, MSc, FRCPC
Sameer Parpia, MSc, PhD
Marcelo Zapata-Canivilo, MD
Walaa Faidi, MSc
Christopher Skappak, MD, PhD
Rachael Gregoris, BHSc
Colin A. Kretz, BSc, PhD
Dhruva J. Dwivedi, BSc, MSc, PhD
Kerstin de Wit, BSc, MSc, MB ChB, MD, FRCPC, FRCEM, MRCP
Michelle Welsford, BSc, MD, FACEP, CCPE, FRCPC
Alison Fox-Robichaud, MSc, MD, FRCPC
on behalf of the Canadian Critical Care Translational Biology Group
Patricia Liaw
Jamie Hutchison
Jane Batt
Sean Gill
Jean-Francois Cailhier
Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study
description Background:. Between 75% and 80% of patients with sepsis arrive in the hospital through the emergency department. Early diagnosis is important to alter patient prognosis, but currently, there is no reliable biomarker. The innate immune response links inflammation and coagulation. Several coagulation -related biomarkers are associated with poor prognosis in the ICU. The role of coagulation biomarkers to aid in early sepsis diagnosis has not previously been investigated. The objective of our study is to determine the individual or combined accuracy of coagulation and inflammation biomarkers with standard biochemical tests to diagnose adult septic patients presenting to the emergency department. Methods:. in the Emergency Department is a prospective, observational cohort study with a target enrolment of 250 suspected septic patients from two Canadian emergency departments. The emergency physicians will enroll patients with suspected sepsis. Blood samples will be collected at two time points (initial presentation and 4 hr following). Patients will be adjudicated into septic, infected, or not infected status in accordance with the Sepsis-3 definitions. Patient demographics, cultures, diagnosis, and biomarkers will be reported using descriptive statistics. Optimal cut off values with sensitivity and specificity for each biomarker will be determined using C-statistics to distinguish between septic and nonseptic patients. Stepwise multiple logistic regression analysis with exclusion of nonsignificant covariates from the final model will be used to establish a panel of biomarkers. Conclusions:. Our protocol describes the processes and methods for a pragmatic observational biomarker study in the emergency department. This study will seek to determine the potential diagnostic importance of early coagulation abnormalities to identify additional tools for sepsis diagnosis.
format article
author Jaskirat Arora, MBBS
Jennifer A. Klowak, MD, MSc, FRCPC
Sameer Parpia, MSc, PhD
Marcelo Zapata-Canivilo, MD
Walaa Faidi, MSc
Christopher Skappak, MD, PhD
Rachael Gregoris, BHSc
Colin A. Kretz, BSc, PhD
Dhruva J. Dwivedi, BSc, MSc, PhD
Kerstin de Wit, BSc, MSc, MB ChB, MD, FRCPC, FRCEM, MRCP
Michelle Welsford, BSc, MD, FACEP, CCPE, FRCPC
Alison Fox-Robichaud, MSc, MD, FRCPC
on behalf of the Canadian Critical Care Translational Biology Group
Patricia Liaw
Jamie Hutchison
Jane Batt
Sean Gill
Jean-Francois Cailhier
author_facet Jaskirat Arora, MBBS
Jennifer A. Klowak, MD, MSc, FRCPC
Sameer Parpia, MSc, PhD
Marcelo Zapata-Canivilo, MD
Walaa Faidi, MSc
Christopher Skappak, MD, PhD
Rachael Gregoris, BHSc
Colin A. Kretz, BSc, PhD
Dhruva J. Dwivedi, BSc, MSc, PhD
Kerstin de Wit, BSc, MSc, MB ChB, MD, FRCPC, FRCEM, MRCP
Michelle Welsford, BSc, MD, FACEP, CCPE, FRCPC
Alison Fox-Robichaud, MSc, MD, FRCPC
on behalf of the Canadian Critical Care Translational Biology Group
Patricia Liaw
Jamie Hutchison
Jane Batt
Sean Gill
Jean-Francois Cailhier
author_sort Jaskirat Arora, MBBS
title Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study
title_short Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study
title_full Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study
title_fullStr Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study
title_full_unstemmed Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study
title_sort diagnostic potential of coagulation-related biomarkers for sepsis in the emergency department: protocol for a pilot observational cohort study
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/97e9fdeb85504be09052fd1bdf14f6b1
work_keys_str_mv AT jaskiratarorambbs diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT jenniferaklowakmdmscfrcpc diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT sameerparpiamscphd diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT marcelozapatacanivilomd diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT walaafaidimsc diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT christopherskappakmdphd diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT rachaelgregorisbhsc diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT colinakretzbscphd diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT dhruvajdwivedibscmscphd diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT kerstindewitbscmscmbchbmdfrcpcfrcemmrcp diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT michellewelsfordbscmdfacepccpefrcpc diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT alisonfoxrobichaudmscmdfrcpc diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT onbehalfofthecanadiancriticalcaretranslationalbiologygroup diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT patricialiaw diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT jamiehutchison diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT janebatt diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT seangill diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
AT jeanfrancoiscailhier diagnosticpotentialofcoagulationrelatedbiomarkersforsepsisintheemergencydepartmentprotocolforapilotobservationalcohortstudy
_version_ 1718413634843967488